Bleichroeder LP 13D/13G Filings for Evoke Pharma, Inc. (EVOK)

Bleichroeder LP 13D and 13G filings for Evoke Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-03-24
6:47 pm
Sale		 2025-03-24 13G Evoke Pharma, Inc.
EVOK		 Bleichroeder LP 158,058
9.990%		 -691,309decrease
(-81.39%)		 Filing
2025-03-21
7:15 pm
Purchase		 2025-03-19 13G Evoke Pharma, Inc.
EVOK		 Bleichroeder LP 849,367
9.990%		 778,586increase
(+1100.00%)		 Filing
2024-03-11
6:39 pm
Purchase		 2024-02-13 13G Evoke Pharma, Inc.
EVOK		 Bleichroeder LP 70,781
9.990%		 70,781increase
(New Position)		 Filing